Dexcom G7 CGM to Be Available to Medicare Beneficiaries at Launch

 

• U.S. Centers for Medicare & Medicaid Services has approved coverage for Dexcom G7, the most accurate,¹ easy-to-use CGM system that helps people with diabetes gain greater control of their health.
• Introduced to the world yesterday in a Super Bowl ad, Dexcom G7 eliminates routine fingersticks^* and builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C and increase time in range.^2-6
• The approval of Medicare coverage for Dexcom G7 further solidifies Dexcom as the most covered and reimbursed CGM brand on the market.⁷
• People with diabetes in the US, including Medicare patients, can visit Dexcom.com/G7 today to get started with Dexcom G7.

https://investors.dexcom.com/news/news-details/2023/Dexcom-G7-Continuous-Glucose-Monitoring-System-Will-Be-Available-to-Medicare-Beneficiaries-at-Launch/default.aspx